N. Ziras

Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem.

N J Lygidakis, N. Ziras, John Parissis · PubMed · 1995 · 66 citations

Surgical Oncology, Colorectal Surgery, Gastroenterology +17

Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)

Dimitriοs Mavroudis, Alexios Matikas, N. Malamos et al. · Annals of Oncology · 2016 · 32 citations

Breast Oncology, Oncology, Docetaxel Versus Docetaxel +9

Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study

N. Ziras, Christos Kosmas, T. Giannakakis et al. · Cancer Chemotherapy and Pharmacology · 2003 · 27 citations

Gastrointestinal Oncology, Randomized Study, Medicine +10

Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.

Aristides Polyzos, Christos Kosmas, Helen Toufexi et al. · PubMed · 2005 · 20 citations

Combination Chemotherapy, Rhg-csf Support, Endocrine-related Cancer +13

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma

T. Giannakakis, N. Ziras, Stylianos Kakolyris et al. · European Journal of Cancer · 2000 · 13 citations

Oncology, Medicine, Pathology +6